{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T17:00:45Z","timestamp":1787245245269,"version":"build-2736575974"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.ygyno.2020.06.492","type":"journal-article","created":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T01:38:17Z","timestamp":1593481097000},"page":"719-726","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Risk of second primary cancers among survivors of gynecological cancers"],"prefix":"10.1016","volume":"158","author":[{"given":"Eric","family":"Adjei Boakye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Logan","family":"Grubb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caryn E.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nosayaba","family":"Osazuwa-Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Grabosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather D.","family":"Ladage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warner K.","family":"Huh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ygyno.2020.06.492_bb0005","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J. Clin."},{"issue":"5","key":"10.1016\/j.ygyno.2020.06.492_bb0010","first-page":"363","article-title":"Cancer treatment and survivorship statistics, 2019","volume":"69","author":"Miller","year":"2019","journal-title":"CA Cancer J. Clin."},{"issue":"2","key":"10.1016\/j.ygyno.2020.06.492_bb0015","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s11764-015-0472-9","article-title":"Survivors of gynecologic malignancies: impact of treatment on health and well-being","volume":"10","author":"Westin","year":"2016","journal-title":"J. Cancer Surviv."},{"issue":"2","key":"10.1016\/j.ygyno.2020.06.492_bb0020","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1001\/jamaoncol.2017.4478","article-title":"Primary cancer vs competing causes of death in survivors of head and neck cancer","volume":"4","author":"Simpson","year":"2018","journal-title":"JAMA Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2020.06.492_bb0025","first-page":"659","article-title":"Risk of second benign brain tumors among cancer survivors in the surveillance, epidemiology, and end results program","volume":"25","author":"Kutsenko","year":"2014","journal-title":"Cancer Causes Control"},{"issue":"5","key":"10.1016\/j.ygyno.2020.06.492_bb0030","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s00432-018-2621-9","article-title":"Multiple primary non-breast tumors in breast cancer survivors","volume":"144","author":"Corso","year":"2018","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2020.06.492_bb0035","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3109\/02841869409121767","article-title":"Secondary malignancies following cancer chemotherapy","volume":"33","author":"Boffetta","year":"1994","journal-title":"Acta Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2020.06.492_bb0040","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.1999","article-title":"Trends in risks for second primary cancers associated with index human papillomavirus-associated cancers","volume":"1","author":"Suk","year":"2018","journal-title":"JAMA Netw. Open"},{"issue":"7","key":"10.1016\/j.ygyno.2020.06.492_bb0045","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1097\/00005537-199707000-00010","article-title":"Factors affecting smoking cessation in patients with head and neck cancer","volume":"107","author":"Ark","year":"1997","journal-title":"Laryngoscope"},{"key":"10.1016\/j.ygyno.2020.06.492_bb0050","doi-asserted-by":"crossref","first-page":"101649","DOI":"10.1016\/j.canep.2019.101649","article-title":"Risk of subsequent malignant neoplasms after an index potentially-human papillomavirus (HPV)-associated cancers","volume":"64","author":"Wang","year":"2020","journal-title":"Cancer Epidemiol."},{"key":"10.1016\/j.ygyno.2020.06.492_bb0055","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ypmed.2016.06.041","article-title":"Risk of second primary cancer after a first potentially-human papillomavirus-related cancer: a population-based study","volume":"90","author":"Neumann","year":"2016","journal-title":"Prev. Med."},{"issue":"10 Suppl","key":"10.1016\/j.ygyno.2020.06.492_bb0060","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1002\/cncr.23746","article-title":"Potential role of human papillomavirus in the development of subsequent primary in situ and invasive cancers among cervical cancer survivors","volume":"113","author":"Balamurugan","year":"2008","journal-title":"Cancer"},{"issue":"21","key":"10.1016\/j.ygyno.2020.06.492_bb0065","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1093\/jnci\/djm201","article-title":"Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk","volume":"99","author":"Chaturvedi","year":"2007","journal-title":"J. Natl. Cancer Inst."},{"issue":"3","key":"10.1016\/j.ygyno.2020.06.492_bb0070","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.radonc.2014.04.011","article-title":"Second primary cancers in survivors of cervical cancer in the Netherlands: implications for prevention and surveillance","volume":"111","author":"Arnold","year":"2014","journal-title":"Radiother. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2020.06.492_bb0075","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.ygyno.2012.09.004","article-title":"Risk of second primary malignancies in women with cervical cancer: a population-based study in Taiwan over a 30-year period","volume":"127","author":"Chen","year":"2012","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2020.06.492_bb0080","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ygyno.2018.07.016","article-title":"Incidences and risk factors of metachronous vulvar, vaginal, and anal cancers after cervical cancer diagnosis","volume":"150","author":"Matsuo","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2020.06.492_bb0085","author":"National Cancer Institute"},{"issue":"11","key":"10.1016\/j.ygyno.2020.06.492_bb0090","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1002\/1097-0142(19951201)76:11<2343::AID-CNCR2820761124>3.0.CO;2-#","article-title":"Completeness of hospital cancer case reporting from the SEER Program of the National Cancer Institute","volume":"76","author":"Zippin","year":"1995","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.ygyno.2020.06.492_bb0095","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1200\/JCO.2003.94.023","article-title":"The surveillance, epidemiology, and end-results program database as a resource for conducting descriptive epidemiologic and clinical studies","volume":"21","author":"Harlan","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2020.06.492_bb0100","series-title":"New Malignancies Among Cancer Survivors: SEER Cancer Registries, 1973-2000, N.C. Institute, Editor.: Bethesda, MD","author":"Curtis","year":"2020"},{"issue":"8","key":"10.1016\/j.ygyno.2020.06.492_bb0105","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1001\/jamaoto.2018.0993","article-title":"Incidence and risk of second primary malignant neoplasm after a first head and neck squamous cell carcinoma","volume":"144","author":"Adjei Boakye","year":"2018","journal-title":"JAMA Otolaryngol. Head Neck Surg."},{"issue":"1","key":"10.1016\/j.ygyno.2020.06.492_bb0110","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/ijc.32101","article-title":"Trends in the risk and burden of second primary malignancy among survivors of smoking-related cancers in the United States","volume":"145","author":"Adjei Boakye","year":"2019","journal-title":"Int. J. Cancer"},{"issue":"8","key":"10.1016\/j.ygyno.2020.06.492_bb0115","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1002\/lary.27634","article-title":"Risk and outcomes for second primary human papillomavirus-related and -unrelated head and neck malignancy","volume":"129","author":"Adjei Boakye","year":"2019","journal-title":"Laryngoscope"},{"key":"10.1016\/j.ygyno.2020.06.492_bb0120","first-page":"64","article-title":"Cancer registration: principles and methods. Classification and coding of neoplasms","volume":"95","author":"Muir","year":"1991","journal-title":"IARC Sci. Publ."},{"key":"10.1016\/j.ygyno.2020.06.492_bb0125","series-title":"The 2007 Multiple Primary and Histology Coding Rules, E. National Cancer Institute Surveillance, and End Results Program, Editor: Bethesda, MD","author":"Johnson","year":"2020"},{"issue":"7","key":"10.1016\/j.ygyno.2020.06.492_bb0130","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1007\/s00432-020-03232-8","article-title":"Risk of second primary cancers in individuals diagnosed with index smoking- and non-smoking- related cancers","volume":"146","author":"Adjei Boakye","year":"2020","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"4 Suppl","key":"10.1016\/j.ygyno.2020.06.492_bb0135","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1002\/1097-0142(197710)40:4+<1892::AID-CNCR2820400820>3.0.CO;2-H","article-title":"Statistical methods for studying multiple primary malignant neoplasms","volume":"40","author":"Schoenberg","year":"1977","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.ygyno.2020.06.492_bb0140","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/oxfordjournals.aje.a117689","article-title":"Methodology for evaluating the incidence of second primary cancers with application to smoking-related cancers from the Surveillance, Epidemiology, and End Results (SEER) program","volume":"142","author":"Begg","year":"1995","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.ygyno.2020.06.492_bb0145","first-page":"1","article-title":"Statistical methods in cancer research. Volume II\u2014The design and analysis of cohort studies","volume":"82","author":"Breslow","year":"1987","journal-title":"IARC Sci. Publ."},{"key":"10.1016\/j.ygyno.2020.06.492_bb0150","first-page":"12(5)","article-title":"Recovery issues in cancer survivorship: a new challenge for supportive care","author":"Alfano","year":"2006","journal-title":"Cancer J."},{"issue":"8","key":"10.1016\/j.ygyno.2020.06.492_bb0155","doi-asserted-by":"crossref","first-page":"883","DOI":"10.6004\/jnccn.2009.0058","article-title":"The challenges of colorectal cancer survivorship","volume":"7","author":"Crystal","year":"2009","journal-title":"J. Natl. Compr. Canc. Netw."},{"issue":"5","key":"10.1016\/j.ygyno.2020.06.492_bb0160","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1002\/ijc.30523","article-title":"HPV status and favourable outcome in vulvar squamous cancer","volume":"140","author":"Wakeham","year":"2017","journal-title":"Int. J. Cancer"},{"issue":"S10","key":"10.1016\/j.ygyno.2020.06.492_bb0165","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1002\/cncr.23764","article-title":"HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women","volume":"113","author":"Gillison","year":"2008","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2020.06.492_bb0170","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.clindermatol.2013.08.007","article-title":"HPV-associated diseases","volume":"32","author":"Ljubojevic","year":"2014","journal-title":"Clin. Dermatol."},{"issue":"7","key":"10.1016\/j.ygyno.2020.06.492_bb0175","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1158\/1055-9965.EPI-07-2753","article-title":"Cervical and vulvar cancer risk in relation to the joint effects of cigarette smoking and genetic variation in interleukin 2","volume":"17","author":"Hussain","year":"2008","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.ygyno.2020.06.492_bb0180","author":"American Cancer Society"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825820323167?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825820323167?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:50:36Z","timestamp":1758772236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825820323167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S0090825820323167"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2020.06.492","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of second primary cancers among survivors of gynecological cancers","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2020.06.492","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}